Trials / Terminated
TerminatedNCT02991768
Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients
Budesonide for Mycophenolic Acid (MPA)-Induced Diarrhea in Renal Transplant Recipients
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- University of Kansas Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to learn if using a Entocort (budesonide) to treat diarrhea will be effective and safe for kidney transplant patients, allowing them to continue with MPA medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Entocort | A corticosteroid that decreases levels of inflammatory cytokines. |
| DRUG | Placebos | Placebo is matched to the study drug. |
Timeline
- Start date
- 2017-01-27
- Primary completion
- 2019-04-26
- Completion
- 2019-04-26
- First posted
- 2016-12-13
- Last updated
- 2024-09-19
- Results posted
- 2024-09-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02991768. Inclusion in this directory is not an endorsement.